Skip to content
8-K

Material Event

Denali Therapeutics Inc. DNLI

0001714899-26-000081

← back to feed
Filed
Jun 18, 2026 8:01 AM ET
Period of report
—

What happened

  • 1.01 Entry into a Material Agreement
  • 7.01 Regulation FD Disclosure
  • 9.01 Financial Statements & Exhibits

On SEC.gov

Primary document ↗ Inline XBRL ↗ Filing index ↗

Financials in this filing

Structured financials aren't available for this filing — it may be an event-driven form (8-K/6-K), pre-date XBRL (~2009), or report only narrative content. Use the SEC.gov links above to read it.